Dr. Babcock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-7370Fax+1 206-985-3201
Summary
- I completed a rich and rewarding, 29 year career as a physician in the US Army and then joined the Cancer and Blood Disorders Center at Seattle Childrens where I work as inpatient Hematologist/Oncologist. I love caring for our patients and their families and could not be happier working with an incredible team at Seattle Childrens. Its an amazing collaborative, supportive, and stimulating environment.
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1989 - 1992
- Tripler Army Medical CenterResidency, Pediatrics, 1984 - 1987
- Baylor College of MedicineClass of 1984
Certifications & Licensure
- MD State Medical License 2012 - 2026
- WA State Medical License 2013 - 2026
- DC State Medical License 1994 - 2022
- HI State Medical License 1986 - 2014
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change Start of enrollment: 2002 May 01
Publications & Presentations
PubMed
- 7 citationsHumoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.Conrad P. Quinn, Carol L. K. Sabourin, Jarad Schiffer, Nancy A. Niemuth, Vera A. Semenova
Clinical and Vaccine Immunology. 2016-04-01 - 3 citationsRecurrent Nocardia Sepsis in a Patient With Sickle Cell Anemia Receiving Continuous Deferoxamine.Jacob M. Wessler, Daniel J. Adams, Anjali N. Kunz, Janiine G. Babcock, Kip R. Hartman
Journal of the Pediatric Infectious Diseases Society. 2014-09-01 - 20 citationsEvaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection...Tracy Pondo, Charles E. Rose, Stacey W. Martin, Wendy A. Keitel, Harry L. Keyserling
Vaccine. 2014-06-12
Journal Articles
- Rapid card-based systems for blood product testingBabcock JG, Holcomb JB, Hess JR, Infusion
- Rodenticide-induced coagulopathy in a young child: A case of Munchausen syndrome by proxyBabcock J, Pedersen A, Murphy M, Harnman K, Alving B., American Journal of Pediatric Hematology/Oncology
Abstracts/Posters
- Kinetics of the Anti-PA Antibody Response to Reduced Schedules of Anthrax Vaccine Adsorbed in HumansC.L. Sabourin, N.A. Niemuth, H.J. Mayfield, T.L. Rudge, V.A. Semenova, H. Li, J. Schiffer, S. Parker, J. Babcock, W. Keitel, G. Poland, H. Keyserling, B.D. Plikaytis,..., Fifth International Anthrax Meeting, BACT
- Anthrax Vaccine Adsorbed (BioThraxTM): A Human Reactogenicity and Immunogenicity Clinical TrialMarano N, Plikaytis B, Martin S, McNeil M, Stamper J, Di Pietra J, Quinn C, Babcock J, Keitel W, Keyserling H, Mulligan M, Poland G, Perkins B, Fifth International Anthrax Meeting, Nice, France
- The recovery and survival of autologous human red cells exposed to 25°C for 24 hoursReid T, Babcock JG, Derse-Anthony CP, Hill HR, Posey LM, Boyce N, Lippert LE, Hess JR, Uniformed Services University for the Health Sciences Symposium, Bethesda, MD
- Join now to see all
Grant Support
- Anthrax Vaccine Research ProgramCenters for Disease Control and Prevention2001–2008
- Development of the Leukotrap® RC AS-24 System and Leukotrap® Whole Blood Filter SystemMedsep Corp1995–1996
Committees
- Chair, W. Reed Army Inst of Research Scientific Review Committee 2007 - 2009
- Member and Senior Subject Matter Expert, Human Subjects Research Review Board for the Surgeon General, US Army 2003 - 2008
Research History
- Collection of Blood Components from Healthy Donors for In Vitro ResearchPrincipal Investigator and Author. Approved November, 2001. Implemented January, 2002. Completed 2007. Associate Investigator 2006 to 2007.2002 - 2007
- Maintenance of Performance and Alertness with Caffeine across Three Nights of Total Sleep DeprivationAssociate Investigator. Conducted July to September 2005.2005 - 2005
- Anthrax Vaccine Adsorbed Microarray Response StudyAssociate Investigator2003 - 2004
- Phase I safety and immunogenicity testing of Group B Meningococcal OMP-dLOS vaccines in healthy volunteersPrincipal Investigator2000 - 2001
- Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli (ETEC) Vaccine Consisting of Heat-labile Toxin of E. coli (LT) and CS6 Colonization Factor Administered TranscutaneouslySub-investigator2000 - 2000
- Evaluation of in Vivo Viability of Red Cells Stored for Prolonged Periods in the Leukotrap® RC AS-24 SystemAuthor and PI until August, 96. Co-investigator until completion in April, 1997.1996 - 1997
- Type Protocol for Measuring the Recovery and Survival of Autologous Human Erythrocytes In VivoPI and Author1995 - 1996
- Phlebotomy Procedures for Use on Human SubjectsPI and Author1994 - 1996
Professional Memberships
- Public Responsibility in Medicine and ResearchMember
- American Society of Pediatric Hematology and OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: